Global Health Office of Pediatrics (GHOPE) Seed Grants
The newly formed Global Health Office of Pediatrics (GHOPE) accepts proposals from Emory or Children’s Healthcare of Atlanta (Children's) faculty members to conduct trainee-engaged pilot research, quality improvement initiatives, or programmatic work in global child health that support sustainable global child health partnerships.
Congratulations to the 2020 awardees! Please see the 'Previous Awardees' tab below for funded projects. New applications are not currently being accepted.
Please note: This RFA was released in tandem with the Center for Clinical Outcomes Research and Public Health (CORPH) 2020 pilot grant RFA, which had different goals and requirements.
- Focused on global child health
- Promote strategic alliance and/or sustained partnership between GHOPE and partner organization
- Have the potential to be expanded/continued in the future (leverage existing resources or lead to new investments from other sources)
- Promote a respectful partnership through mutuality in planning, implementation, and evaluation
- Be endorsed by partner organization
Priority Populations and Locations: Children, adolescents, and women in the periconceptual or perinatal periods in any low-resource setting, such as one of Emory’s priority countries, a GHOPE existing partner country (Ethiopia, Brazil, Tanzania), other low and middle-income countries, or low-resource communities or populations in the United States.
Amount: Up to $10,000 total for budget period lasting 12 months
Project Period: October 1 - September 30
- The principal investigator must have a primary faculty appointment in the Emory Department of Pediatrics or Pediatric Institute, or be on the professional staff of Children's, and
- The co-principal investigator must be a fellow or resident.
Requirements: The principal investigators must:
- Submit progress reports every 6 months during the project period.
- Submit a final report within 2 months after the project end date.
- Submit post project report(s) 1 year after the project end date.
- Present the results of the project at a local symposium, such as GHOPE Research Day.
Applications must include separate PDF files for each of the following items. All documents must be single-spaced, Arial 11 font, with 1" margins:
- NIH-style biosketches for both principal investigators
- Main proposal (max. 3 pages total plus references)
- Hypothesis/specific aims/project goals
- Methods/experimental design/project description
- Impact and relevance to global child health
- Description of the end-product that will communicate the results of the project (e.g. presenting an abstract at a regional or national meeting in your field, a manuscript or a grant application to further the research project)
- Sustainability plan
- Project timeline
- (If applicable) Protections for Human Subjects Section
Applications also must include:
- Abstract that includes the specific aims (max. 1 page - no references)
- Detailed line item budget in required Excel template and detailed budget justification
- Letter of support from the partner organization
- Letter of support from division director committing to support of the proposed project, support of the resident/fellow to participate in the project, and support of any in kind effort
Required Budget Templates
Note: It is strongly recommended that a financial analyst review and approve your budget prior to submission. Please see the Help tab of this RFA for a list of analysts. In addition, if your budget includes the Pediatric Biostatistics Core, it is strongly recommended that you consult with the core prior to preparing your budget to get an official estimate of the time needed to complete your project.
All applications must be submitted electronically through the online application portal:
- Start a new GHOPE Pilot Grant Application
- Resume a Saved Application (or access a previously submitted application)
Parmi S. Suchdev, MD, MPH, FAAP
Associate Director, Emory Global Health Institute
Director, Global Health Office of Pediatrics
Professor, Department of Pediatrics and Hubert Department of Global Health
General Application Questions
Budget Related Questions
Please contact the financial analyst for your division:
- Allergy, Cystic Fibrosis, Pulmonology, Sleep: Lynnessa Snodgrass
- LOBP: Bill Ollinger
- Emergency Medicine, Endocrinology, ENT, Nephrology, Rheumatology: Clarissa Scott
- Critical Care, Hospital Medicine, Marcus, Neonatology, Neurology: Margie Varnado
- Leukemia Lymphoma, Neuro-Oncology: Melissa Maxwell
- Gastroenterology, General Pediatrics, Palliative Care: Preethi Reddy-Veluri
- Cardiology, Infectious Disease: Shannon Jafolis
- BMT, Gene Therapy, Hematology, HemThrom, Sickle Cell, Solid Tumor, Survivor: Stephanie Shannon
Congratulations to the investigators whose projects were selected for funding in the inaugural round of the Global Health Office of Pediatrics (GHOPE) Pilot Grant Program! Click here for the news announcement.
Toward Expanding Uptake of Maternal Vaccination in Ethiopia: A Systems-Based Approach to Understanding Catalysts and Catches of Maternal Immunization
Lisa Cranmer, MD, MPH & Elizabeth Quincer, MD
STIGMA: Decreasing Stigma During Healthcare Transition Through an Iteratively Designed Group-Based Social Media Motivational Interviewing Intervention for Adolescents Living with HIV in South Africa
Brian Zanoni, MD, MPH & Madeleine Goldstein, DO
Heavy Metal Toxicity and Community Risk Perceptions in Pediatric Populations after the Brumadinho Mining Disaster in Brazil
Rebecca Philipsborn, MD, MPA & Kristine Sufcak, MD
Frequently Asked Questions
What types of projects may be supported by these grants?
All proposals must include appropriate, specific, measurable performance goals and targets and be feasible within the identified timeframe and budget. Any of the following project types will be considered:
- Research (outcomes, translational, epidemiologic, and behavioral)
- Health policy development and implementation
- Health promotion or education
- Health systems strengthening and capacity building
- Program evaluation
- Quality Improvement
What are allowable expenses?
- Travel & communication for project
- Data collection
- Data analyses using biostats core
- Planning and start-up activities
- Travel to conferences to present results
- Equipment or material costs
- Publication fees (not covered by Emory Open Access Fund)
What are unallowable expenses?
- Travel for trainees to present the results of the project at conferences. Faculty members may include a maximum of $1,500 for conference-related travel expenses.
- Resident or fellow salary
- Faculty effort (should be in-kind within budget and approved by division director)
- Emory/Children's staff time is discouraged unless necessary (please include strong justification in proposal.)
- Indirect costs should not be included.
What happens to funds not spent by the project end date?
- All funds not spent by the project end date are returned to GHOPE.
What happens if I cannot complete my project by the project end date?
- All awardees may request one 12-month no cost extension (NCE) of the project period. Strong justification is required, and the request must be submitted in the grants management portal at least 60 days prior to the original project end date.
What does it mean to be on the professional staff of Children's?
- According to CHOA’s Professional Staff Organization Manual, professional staff means “all physicians, dentists, and psychologists who are granted appointment to the Children's Professional Staff and clinical privileges to treat patients at or through any of the components of Children's.” A psychologist is “a doctor of psychology (“PhD” or “PsyD”) licensed to practice in the State of Georgia.”
Where can I find biosketch instructions and resources?
- Biosketch Instructions
- Example Biosketch for Postdoctoral Researchers
- Preparing Your CV and Biosketch by Dr. Stacy Heilman - Presentation & Slides
- Preparing Your Biosketch by Dr. Stacy Heilman - Presentation
How do I write a budget justification?
- Please review these example Budget Justification Categories.
What do I need to know about human subjects research?
How do I know if my project needs to be submitted to the IRB?
- If you are unsure whether your project is human subjects research, we recommend that you request an official determination from the IRB.
- The following questions may help you determine whether a project needs to be reviewed by the IRB:
- Is the project research - a systematic investigation designed to contribute to generalizable knowledge? The NIH definition of clinical research is available here. If yes or uncertain, submit to the IRB. If no, no submission is required to the IRB.
- Is your project research with human subjects - a living individual about whom you are collecting identifiable information? If yes or uncertain, submit to the IRB. If no, no submission is required to the IRB.
- Potential IRB determinations may include:
- The project does not require IRB review because it does not meet the definition of research with human subjects or clinical investigations.
- The project is human subjects research, but is exempt from further IRB review and approval because it meets the criteria for exemption under 45 CFR 46.101(b). Explanations of exempt categories are available here. An example of a project that may result in this determination is a retrospective chart review using data previously collected for research purposes. Only an IRB can determine if a project meets the criteria for exemption.
- The project qualifies for expedited IRB review. Explanations of expedited categories are available here. Only an IRB can determine if a project meets the criteria for expedited review.
- The project requires full IRB review.
- The HHS Office for Human Research Protections' decision chart provides a helpful visual.
My project involves human subjects research that is covered under a pre-existing approved IRB protocol for a larger study. What IRB information should I submit?
- Complete all IRB questions on the application.
- Upload a copy of the approved IRB protocol and highlight the content related to your project.
My project uses human specimens collected under a protocol for a different study that included a statement in the consent form that gave permission for the specimens to be used for future research. Is my project still considered human subjects research?
- Yes, your project is still considered human subjects research.
- Answer yes to the human subjects question and complete all IRB fields on the application.
- Highlight the portion of the IRB protocol that specifically relates to your project, including the statement in the consent form that gives permission for the specimens to be used for future research.
How do I know if I need to include a Protections for Human Subjects Section and Target Enrollment Table?
- If the IRB states that a Protections for Human Subjects Section and Target Enrollment Table are required, then you need to include these documents with your application *even if* you have not yet submitted them to the IRB.
- Applications that are missing these two documents will be considered incomplete and will not be accepted.
- Regarding the Target Enrollment Table:
- You must use the NIH template for this table.
- Ensure your total planned enrollment equals the total of all subjects.
- If your project uses a convenience sample or existing deidentified data, you should estimate enrollment based on the characteristics of the population you're recruiting from.
- It is not sufficient to state, "We will enroll male and female patients from all ethnic and racial categories." Most populations do not include equal representation of all racial categories (i.e. there are not typically equal numbers of whites and American Indian/Alaska Natives in most populations).
Do I need a Protections for Human Subjects Section if I am only conducting a chart review?
- Yes, you must include a Protections for Human Subjects Section even if your project is a retrospective chart review.
- This section should detail the following points:
- The project entails no more than minimal risks to patients, the data was already collected for clinical care, any sensitive data being collected, minimized personal identifiers, how data will be stored, steps to minimize the risk of breach of confidentiality, etc.
- Waiving consent; is the data being collected from procedures that would occur regardless of the research study, will there be findings that could impact their ongoing care, will the results from the study be placed in the patient’s medical record, will there be any contact with the patients whose records are being accessed for the study, etc.